Northwest Biotherapeutics Inc (NWBO): Revenue
$1.38M
Year ended 2025-12-31
$2.17M
Trailing 12 months to 2026-06-30
-6.4%
3-year compound annual growth
+1.3%
5-year compound annual growth
-2.3%
10-year compound annual growth
| Period ended | Revenue | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $1.38M | -0.3% | 2026-04-15, From 2025-01-01 |
| 2024-12-31 | $1.38M | -28.5% | 2026-04-15, From 2024-01-01 |
| 2023-12-31 | $1.93M | +14.8% | 2025-03-31, From 2023-01-01 |
| 2022-12-31 | $1.68M | +67.5% | 2024-03-05, From 2022-01-01 |
| 2021-12-31 | $1.00M | -22.2% | 2024-03-05, From 2021-01-01 |
| 2020-12-31 | $1.29M | -46.4% | 2023-02-28, From 2020-01-01 |
| 2019-12-31 | $2.41M | +485.0% | 2022-03-01, From 2019-01-01 |
| 2018-12-31 | $412.0K | +22.6% | 2020-03-16, From 2018-01-01 |
| 2017-12-31 | $336.0K | -46.1% | 2019-04-02, From 2017-01-01 |
| 2016-12-31 | $623.0K | -64.2% | 2018-04-17, From 2016-01-01 |
| 2015-12-31 | $1.74M | +19.6% | 2017-04-17, From 2015-01-01 |
| 2014-12-31 | $1.45M | +79.7% | 2016-03-16, From 2014-01-01 |
| 2013-12-31 | $809.0K | +4.8% | 2016-03-16, From 2013-01-01 |
| 2012-12-31 | $772.0K | n/m | 2014-04-01, From 2012-01-01 |
| 2011-12-31 | $10.0K | 0.0% | 2013-04-08, From 2011-01-01 |
| 2010-12-31 | $10.0K | n/a | 2012-04-13, From 2010-01-01 |
Revenue at similar companies
| Company | Year ended | Revenue | Change YoY |
|---|---|---|---|
| Northwest Biotherapeutics Inc (NWBO) | 2025-12-31 | $1.38M | -0.3% |
| Cannapharmarx, Inc. (CPMD) | 2025-12-31 | $1.36M | +66.1% |
| Avenue Therapeutics, Inc. (ATXI) | 2025-12-31 | $1.40M | n/a |
| NRX Pharmaceuticals, Inc. (NRXP) | 2025-12-31 | $1.45M | n/a |
| IGC Pharma, Inc. (IGC) | 2025-03-31 | $1.27M | -5.5% |
| Vistagen Therapeutics, Inc. (VTGN) | 2026-03-31 | $1.27M | +161.1% |
| Longeveron Inc. (LGVN) | 2025-12-31 | $1.20M | -49.9% |
| Neuphoria Therapeutics Inc. (NEUP) | 2026-06-30 | $1.17M | -92.5% |
| Rani Therapeutics Holdings, Inc. (RANI) | 2025-12-31 | $1.63M | +58.9% |
Compare NWBO, CPMD, ATXI, NRXP side by side · Screen every company in Pharmaceutical Preparations ↗